Abernethy, Matthew Charles
At least 2 active companies
These details are public data from the Companies House register.
- Nationality
- American
- Country of residence
- United States
Appointments 2 current
Not a complete list. See all appointments on Companies House
Director · Appointed 26 May 2022
Active
Net assets £100, 2022 accounts (newer filed) · Incorporated 2022
Works with
Officers serving alongside Abernethy, Matthew Charles
Bradfute, David Lyle
Director at Soleno Therapeutics UK Ltd
Corporate Secretary at Neurocrine UK Limited